annb0t
Top 20
AFT Pharmaceuticals (NZSE:AFT) First Half 2023 Results
Key Financial Results
Revenue: NZ$65.8m (up 18% from 1H 2022). Net income: NZ$1.45m (down 66% from 1H 2022). Profit margin: 2.2% (down from 7.6% in 1H 2022). The decrease in margin was driven by higher expenses. EPS: NZ$0.01 (down from NZ$0.04 in 1H 2022). earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
AFT Pharmaceuticals Earnings Insights
Looking ahead, revenue is forecast t...
>>> Read more: AFT Pharmaceuticals First Half 2023 Earnings: EPS: NZ$0.01 (vs NZ$0.04 in 1H 2022)
Key Financial Results
Revenue: NZ$65.8m (up 18% from 1H 2022). Net income: NZ$1.45m (down 66% from 1H 2022). Profit margin: 2.2% (down from 7.6% in 1H 2022). The decrease in margin was driven by higher expenses. EPS: NZ$0.01 (down from NZ$0.04 in 1H 2022). earnings-and-revenue-history
All figures shown in the chart above are for the trailing 12 month (TTM) period
AFT Pharmaceuticals Earnings Insights
Looking ahead, revenue is forecast t...
>>> Read more: AFT Pharmaceuticals First Half 2023 Earnings: EPS: NZ$0.01 (vs NZ$0.04 in 1H 2022)
